In consistent with such reports, our findings indicate that ERK is dramatically activated under BPH conditions and subsequently returned to normal levels by BBR treatment, but phosphorylation levels of JNK and p38 were not significantly affected in BPH-induced rats (Figure 3). The gene discussed is MAPK14; the disease is benign prostatic hyperplasia.